Post Market Clinical Follow up of ResMed Mask Systems

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorResMed

About this trial

Post Market follow up study to systematically and proactively collect supplementary real world data to confirm the usability and performance of the new generation mask systems. .

Eligibility criteria

Qualifiers

Participants willing to give written informed consent

Participants who can read and comprehend English

Participants who ≥ 18 years of age

Participants being treated for OSA for ≥ 6 months

Disqualifiers

Participants using Bilevel flow generators

Participants who are or may be pregnant

Participants with a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury.

Participants believed to be unsuitable for inclusion by the researcher

Trial design

Treatments tested in this trial

  • New generation CPAP mask

Treatment groups

500 Participants
are divided into 1 treatment group

Sponsors and collaborators